Navigation Links
Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia
Date:3/26/2012

 

p=0.59

p=0.42Responder Analysis 

 

 

 "Much Improved or Very Much Improved" 

 

 

   Clinical Global Impression-Tardive Dyskinesia

n/a

52%

65%

60%  Patient Global Impression of Change

n/a

39%

53%

60%  Excluding Single Site Baseline(mean)Placebo12.5mg50mgAbnormal Involuntary Movement Scale (LS Means)14.9

10.3

9.9

6.1 

 

 

p=0.68

p=0.002Responder Analysis end of Treatment 

 

 

 "Much Improved or Very Much Improved" 

 

 

 Clinical Global Impression-Tardive Dyskinesia

n/a

46%

67%

80%Patient Global Impression of Change

n/a

38%

62%

80%Safety ProfileNBI-98854 was generally safe and well tolerated; the frequency of treatment-emergent adverse events was 17% during the placebo period and 24% and 32% in the 12.5mg and 50mg treatment periods, respectively. There were no serious adverse events during the treatment period. The most common adverse event was headache and one subject in the 50mg group discontinued due to akathisia. The underlying psychiatric state of subjects was monitored using the Brief Psychiatric Ratings Scale (BPRS) and shown to be stable or improved across study groups declining from 32 at baseline to 28 at the end of the study. There were no drug-drug interactions identified in subjects who were utilizing a range of psychotropic and other concomitant medications.

"While not ideal, this study served its primary purpose of informing the larger Phase IIb studies. The 50mg once-daily dose of NBI-98854 provided tardive dyskinesia sufferers with a remarkable improvement of symptoms, coupled with an excellent
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock
2. Neurocrine Biosciences, Inc. Announces Proposed Public Offering of Common Stock
3. Neurocrine Mourns the Passing of Founder and Board Member Wylie Vale, Ph.D.
4. Neurocrine Biosciences to Present at the 30th Annual J.P. Morgan Healthcare Conference
5. Neurocrine Biosciences to Present at the 23rd Annual Piper Jaffray Health Care Conference
6. Neurocrine Biosciences to Present at the 2011 Credit Suisse Annual Health Care Conference
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2011 Financial Results
8. Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement
9. Neurocrine Biosciences Announces Elagolix Scientific Presentations at the 67th Annual Meeting of the American Society for Reproductive Medicine
10. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
11. Neurocrine Biosciences Announces the Start of Phase II Study of Elagolix in Uterine Fibroids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... , April 20, 2015 The preclinical contract ... pharmacokinetic testing of drugs and safety testing of medical devices, ... present at this week,s workshop " Drug Transporters in ADME: ... Baltimore, MD . The title of Dr. Hidalgo,s talk ... of a session entitled "Transporter Tools of the Future." ...
(Date:4/20/2015)...  Teradata (NYSE: TDC ), the ... company, today announced the newest analytic innovation ... Life Sciences helps organizations integrate and analyze data ... (RED), clinical analysis, Real-World Evidence (RWE), and finance. ... can benefit by bringing safer, more effective treatments ...
(Date:4/20/2015)... April 20, 2015   Gateway Rehab ... Training Institute today expanded its Naloxone: Increasing Access, ... A $50,000 grant from the Staunton Farm ... possible.  The yearlong research project, ... and their family members upon completion of treatment ...
Breaking Medicine Technology:Absorption Systems Chief Scientist Ismael Hidalgo to Present at International Workshop on Drug Transporters 2Teradata Delivers Big Analytics Innovation for Life Sciences 2Teradata Delivers Big Analytics Innovation for Life Sciences 3Teradata Delivers Big Analytics Innovation for Life Sciences 4Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 2Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 3
... N.Y., March 2, 2011 Lixte ... that the company has received a $244,479.25 grant ... awarded to further development and commercialization of Lixte,s novel anti-cancer ... the Patient Protection and Affordable Care Act of 2010 to ...
... 2011 InspireMD , developer ... has expanded its MGuard production facilities to meet the ... accelerating demand for MGuard include the recent recommendation of ... be considered for PCI of highly thrombotic or SVG ...
Cached Medicine Technology:Lixte Biotechnology Holdings, Inc. Awarded Grant Under Qualifying Therapeutic Discovery Project from the U. S. Government 2InspireMD Boosts MGuard Production Capacity 2
(Date:4/20/2015)... Lake City, Utah (PRWEB) April 20, 2015 ... End of Employer-Provided Health Insurance: Why It’s Good for ... 30, 2015. , Paul Zane Pilzer and Rick Lindquist ... of Employer-Provided Health Insurance: Why It’s Good for You ... to our nation’s employer health insurance woes - employer-funded ...
(Date:4/20/2015)... New York (PRWEB) April 20, 2015 ... association representing the U.S. health insurance industry, is ... result of the recent controversy involving surgical tools ... letter to U.S. Senator Robert Casey (D-PA) dated ... concerns surrounding uterine morcellation point to “serious gaps ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 “ Verus ... monthly Tech Report, which features the latest and coolest ... expert and special reporter for NewsWatch, conducted the review ... for a variety of purposes. , According to CNET, ... shattered screen in 2013. It’s unfortunate that smartphones break ...
(Date:4/20/2015)... 20, 2015 Northern Westchester Hospital ... Medicaid Services introduced their new 5-star “Patient Experience” rating ... of Healthcare Providers and Systems) survey of hospital patient ... their experiences during a recent hospital stay. ... 2013 through June 30, 2014 can be reviewed online ...
(Date:4/20/2015)... Dallas, Texas (PRWEB) April 20, 2015 ... Global Amlodipine Besylate Industry is a professional and ... global Amlodipine Besylate Market with a ... companies included in the amlodipine besylate market research ... Sun Pharmaceutical, Dr. Reddy's Lab., Par Pharma, Cadila ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 4Health News:Attractive and Durable Phone Cases were Featured on NewsWatch Television 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 3Health News:Global Amlodipine Besylate Industry 2015-2020 Forecast Analysis Report 2Health News:Global Amlodipine Besylate Industry 2015-2020 Forecast Analysis Report 3
... The ... by empowering its patients with education about liposuction and body sculpting procedures, reaffirming their trust ... ... its commitment to patient education. The Soluna MD staff, led by general and cosmetic surgeon ...
... , ... California family whose child is thriving in the special education ... teaching fear through over protectiveness. This family is sharing their story of ... lack of sight due to an extremely premature birth and its complications. ...
... ... and reduced stress by aiding in the creation of healthy serotonin levels , ... Springville, UT (PRWEB) June 16, 2010 -- ... more restorative and restful sleep ; reduces cravings for junk food; and assists with ...
... experts assembled by the American Diabetes Association and ... suggests cancer incidence is associated with diabetes as ... The new report reviews the state of science ... risk factors common to both diseases; possible biologic ...
... ... to Colorado as Executive Director of the Linda Crnic Institute for Down syndrome at the ... ... MD, PhD, has been tapped to become the first Executive Director of the Linda ...
... virus that causes chickenpox and shingles could lead to improved ... the University of Edinburgh devised a technique to separate the ... to a biochip, before incubating the chip with blood from ... able to pinpoint which proteins in the virus triggered a ...
Cached Medicine News:Health News:Miami's Soluna MD Educates Patients, Gains International Reputation for Excellence in Laser Lipo plus Ultrasound Technique, SmartLipo™ Ultra 2Health News:Miami's Soluna MD Educates Patients, Gains International Reputation for Excellence in Laser Lipo plus Ultrasound Technique, SmartLipo™ Ultra 3Health News:California Family Raising Confident, Blind Child Sharing Successes to Change Perceptions of Blindness 2Health News:California Family Raising Confident, Blind Child Sharing Successes to Change Perceptions of Blindness 3Health News:California Family Raising Confident, Blind Child Sharing Successes to Change Perceptions of Blindness 4Health News:Healthy Serotonin Levels Shown to Positively Affect many Important Functions of the Mind and Body. 2Health News:Experts explore emerging evidence linking diabetes and cancer 2Health News:Experts explore emerging evidence linking diabetes and cancer 3Health News:Renowned Geneticist Heralds in New Era for People with Down Syndrome 2Health News:Renowned Geneticist Heralds in New Era for People with Down Syndrome 3Health News:Renowned Geneticist Heralds in New Era for People with Down Syndrome 4
ELISA kit for the quantitative determination of autoantibodies to IA-2 in serum...
Inquire...
Bench Top Class I Containment Cabinet Personnel Protection...
Inquire...
Medicine Products: